Tag: Marcus Schindler
Novo Nordisk signs $3.3bn deal to acquire Dicerna Pharmaceuticals
Novo Nordisk has signed a deal worth around $3.3 billion to acquire Dicerna Pharmaceuticals, a US-based biotech company focused on developing ribonucleic acid interference (RNAi) ... Read More
Novo Nordisk acquires glucose binding molecules developer Ziylo
Novo Nordisk acquisition of Ziylo : Danish pharma company Novo Nordisk has acquired Ziylo, a University of Bristol spin-out biotechnology company, in a deal that ... Read More